3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
28
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Triple Negative Breast Neoplasms
2
Radiation Injuries
1
Neoplasms
1
Lymphedema
1
Lymphatic Metastasis
1
Deception
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Paclitaxel
26
pembrolizumab
24
Docetaxel
20
Capecitabine
19
Fulvestrant
17
Trastuzumab
16
Anastrozole
15
Cyclophosphamide
14
Lapatinib
13
Letrozole
11
Carboplatin
11
Radiotherapy
10
Doxorubicin
10
palbociclib
9
Therapeutics
9
Nivolumab
9
Exercise
9
Gemcitabine
8
Cisplatin
8
Blood Specimen Collection
8
Tamoxifen
7
Bevacizumab
7
liposomal doxorubicin
6
exemestane
6
abemaciclib
6
Vinorelbine
6
Standard of Care
6
Fluorouracil
6
atezolizumab
5
Surveys and Questionnaires
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Radiation Dose Hypofractionation
×
Breast
×
Clear all
NCT01936961
2017-06-27
I-CREST
Western Regional Medical Center
Phase NA
Withdrawn